4DX 6.09% 54.0¢ 4dmedical limited

Ann: 1H FY2024 Investor Presentation, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,533 Posts.
    lightbulb Created with Sketch. 613
    xmlmillr6 (tga.gov.au)

    xmlmillr6 (tga.gov.au)

    Looks like Imbio received TGA approvals in late calendar year 2021 for their Lung Density Analysis (LDA) and Lung Texture Analysis (LTA) products, but probably never got around to commercialising it in Australia - presumably due to competing demands for capital. 4DX has the know-how and networks to get this to market quickly (synergies) - with all their learnings to date and existing contracts.

    What's interesting is the LTA which yesterday was announced will be used by the VA in the context of lung cancer screening. Well, in Australia, we've got the lung cancer screening funded and due to start in the near future. We can sell this to the govt as an additional tool in the screening process along with our XV technology - to give a comprehensive picture of the patient's lungs.
 
watchlist Created with Sketch. Add 4DX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.